Not applicableWithdrawnNCT03087370What this trial is testingA Retrospective and Prospective Natural History Study of Patients With WHIM SyndromeWho this might be right forWHIM Syndrome X4 Pharmaceuticals
Large-scale testing (Phase 3)Active Not RecruitingNCT03995108What this trial is testingEfficacy and Safety Study of Mavorixafor in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) SyndromeWho this might be right forWHIM Syndrome X4 Pharmaceuticals 31
Testing effectiveness (Phase 2)Study completedNCT03005327What this trial is testingA Dose Determination and Safety Study of X4P-001 (Mavorixafor) in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) SyndromeWho this might be right forWHIM Syndrome X4 Pharmaceuticals 8
Testing effectiveness (Phase 2)Looking for participantsNCT00967785What this trial is testingA Phase I Study of Mozobil in the Treatment of Patients With WHIMSWho this might be right forLeukopeniaNeutropeniaInfections+2 more National Institute of Allergy and Infectious Diseases (NIAID) 20
Large-scale testing (Phase 3)Study completedNCT02231879What this trial is testingPlerixafor Versus G-CSF in the Treatment of People With WHIM SyndromeWho this might be right forMyelokathexisInfectionsNeutropenia+2 more National Institute of Allergy and Infectious Diseases (NIAID) 20
Early research (Phase 1)Study completedNCT01058993What this trial is testingAMD 3100 for Treatment of MyelokathexisWho this might be right forNeutropenia University of Washington 6